BNP/CALL/MERCK & CO./135/0.1/17.01.25 Share Price

Warrant

DE000PC4AJL8

Market Closed - Boerse Frankfurt Warrants 01:20:31 01/06/2024 am IST
0.48 EUR +2.13% Intraday chart for BNP/CALL/MERCK & CO./135/0.1/17.01.25
1 month-32.39%
3 months-30.43%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/24/31 0.48 +2.13%
30/24/30 0.47 -4.08%
29/24/29 0.49 -.--%
28/24/28 0.49 -22.22%
27/24/27 0.63 -.--%

Real-time Boerse Frankfurt Warrants

Last update May 01, 2024 at 01:20 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC4AJL
ISINDE000PC4AJL8
Date issued 31/01/2024
Strike 135 $
Maturity 17/01/2025 (229 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.95
Lowest since issue 0.41
Spread 0.01
Spread %2.04%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus